| Payment Type: | L/C,T/T,D/P,Paypal,Money Gram,Western Union |
|---|---|
| Incoterm: | FOB,CFR,CIF,EXW,FCA,CPT,CIP |
| Min. Order: | 10 Gram |
| Delivery Time: | 7 Days |
Basic Info
Model No.: TF-2013
Type: Pharmaceutical Intermediates
Appearance: Powder
Quality: Industrial
Colour: White
Additional Info
Packaging: As Buyer's Request
Productivity: 100Ton
Brand: Tianfu
Transportation: Ocean,Land,Air,DHL，TNT
Place of Origin: China
Supply Ability: 50Ton
Certificate: ISO
Port: Shanghai port,Qingdao port
Product Description
Application
Drug Indication: Bimatoprost is a cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
from MeSH
Bimatoprost is a Prostaglandin Analog. The chemical classification of bimatoprost is Prostaglandins.
FDA Pharmacology Summary from FDA Pharm Classes
Bimatoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes. It binds to the prostanoid FP receptor.
Formulations/Preparations
Bimatoprost ophthalmic (eye) drop, 0.03% (3 mL, 5 mL)
| Handling and storage | |
| Safety and Hazards | Handling should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes. |
| Handling and storage | Preserve at ambient temperature and in well-close containers. |
| Sample package | Aluminium foil bag |
| Commercial package | Aluminium tin |
| UN Code | Not classfied |
| HS Code | 29375000 |
| Shipping group | Shipment at ambient temperature for no controlled and no dangerous goods |
| Sales restriction | NO |
| Origin | China |
| Chemical and Physical Properties | |
| Appearance | White or almost white crystalline powder |
| Melting Point | 60.0~70.0℃ |
| Solubility | Slightly soluble |
| Quality standard | Purity 99% min |
.png)
Contact Now
